Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals

被引:38
作者
Pietrzak, Robert H. [2 ]
Snyder, Peter J. [1 ]
Jackson, Colleen E. [3 ,4 ]
Olver, James [5 ]
Norman, Trevor [5 ]
Piskulic, Danijela [5 ]
Maruff, Paul [6 ,7 ]
机构
[1] Brown Univ, Warren Alpert Med Sch, Dept Clin Neurosci, Providence, RI 02912 USA
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[3] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA
[4] Univ Connecticut, Dept Psychol, Storrs, CT USA
[5] Univ Melbourne, Sch Med, Dept Psychiat, Melbourne, Vic, Australia
[6] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia
[7] CogState Ltd, Melbourne, Vic, Australia
关键词
schizophrenia; cognition; neuropsychology; reliability and validity; variability; PHASE CLINICAL-TRIALS; WORKING-MEMORY; PERFORMANCE; DEFICIT; BATTERY; METAANALYSIS; VARIABILITY;
D O I
10.1002/hup.998
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective This study examined between- and within-subject stability of cognitive performance in individuals with chronic schizophrenia. Methods Thirty individuals with schizophrenia and 20 healthy controls matched by age, sex, education, and estimated IQ underwent repeated cognitive assessments at baseline and 30 days using computerized tests of psychomotor function, visual attention/information processing, non-verbal learning, and executive function. Results Compared to healthy controls, individuals with schizophrenia scored lower on all cognitive measures and demonstrated greater variability in cognitive performance. Within-subject variability in cognitive performance in both the schizophrenia and healthy control groups remained stable at brief (i.e., hours) and intermediate (i.e., one month) assessments. Conclusions These results demonstrate the stability of between- and within-subject variability in cognitive performance in schizophrenia, and suggest that variability in cognitive performance may reflect an inherent characteristic of the disorder, rather than differences in test-retest reliability/error of cognitive measures. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 49 条
[1]   THE STEPPING-STONE MAZE: A DIRECTLY VISIBLE SPACE-PROBLEM APPARATUS [J].
Barker, Roger G. .
JOURNAL OF GENERAL PSYCHOLOGY, 1931, 5 (02) :280-285
[2]   The perception of self-produced sensory stimuli in patients with auditory hallucinations and passivity experiences: evidence for a breakdown in self-monitoring [J].
Blakemore, SJ ;
Smith, J ;
Steel, R ;
Johnstone, EC ;
Frith, CD .
PSYCHOLOGICAL MEDICINE, 2000, 30 (05) :1131-1139
[3]  
Bland JM, 1996, BRIT MED J, V313, P744
[4]   Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms [J].
Brazo, P ;
Delamillieure, P ;
Morello, R ;
Halbecq, I ;
Marié, RM ;
Dollfus, S .
PSYCHIATRY RESEARCH, 2005, 133 (01) :45-55
[5]   Cognitive patterns in subtypes of schizophrenia [J].
Brazo, P ;
Marié, RM ;
Halbecq, I ;
Benali, K ;
Segard, L ;
Delamillieure, P ;
Langlois-Théry, S ;
Van der Elst, A ;
Thibaut, F ;
Petit, M ;
Dollfus, S .
EUROPEAN PSYCHIATRY, 2002, 17 (03) :155-162
[6]  
CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578
[7]  
Cohen J., 1988, Statistical power analysis for the behavioural sciences, V2nd
[8]   The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals [J].
Collie, A ;
Maruff, P ;
Darby, DG ;
McStephen, M .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2003, 9 (03) :419-428
[9]   Cognitive testing in early-phase clinical trials: Development of a rapid computerized test battery and application in a simulated Phase I study [J].
Collie, Alex ;
Darekar, Amanda ;
Weissgerber, Georges ;
Toh, Melvin K. ;
Snyder, Peter J. ;
Maruff, Paul ;
Huggins, John P. .
CONTEMPORARY CLINICAL TRIALS, 2007, 28 (04) :391-400
[10]   Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study [J].
Collie, Alex ;
Maruff, Paul ;
Snyder, Peter J. ;
Darekar, Amanda ;
Huggins, John P. .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (07) :481-488